C$1.90
0.53%
Toronto, Oct 03, 10:00 pm CET
ISIN
CA1380351009
Symbol
WEED

Canopy Growth Corporation Stock price

C$1.90
-0.02 1.04% 1M
+0.52 37.68% 6M
-2.04 51.78% YTD
-4.33 69.50% 1Y
-37.50 95.18% 3Y
-196.30 99.04% 5Y
-15.00 88.76% 10Y
+1.75 1,166.67% 20Y
Toronto, Closing price Fri, Oct 03 2025
+0.01 0.53%
ISIN
CA1380351009
Symbol
WEED
Industry

Key metrics

Basic
Market capitalization
C$639.3m
Enterprise Value
C$823.5m
Net debt
C$184.2m
Cash
C$143.6m
Shares outstanding
205.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.3 | 2.1
EV/Sales
3.0 | 2.7
EV/FCF
negative
P/B
1.3
Financial Health
Equity Ratio
53.1%
Return on Equity
-122.8%
ROCE
-9.0%
ROIC
-10.0%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
C$274.9m | C$304.6m
EBITDA
C$-49.1m | C$-17.2m
EBIT
C$-72.7m | C$-92.9m
Net Income
C$-512.5m | C$-142.6m
Free Cash Flow
C$-133.1m
Growth (TTM | estimate)
Revenue
-4.3% | 13.2%
EBITDA
56.4% | 71.1%
EBIT
47.9% | -10.7%
Net Income
31.3% | 76.2%
Free Cash Flow
30.2%
Margin (TTM | estimate)
Gross
27.8%
EBITDA
-17.9% | -5.7%
EBIT
-26.4%
Net
-186.4% | -46.8%
Free Cash Flow
-48.4%
More
EPS
C$-2.7
FCF per Share
C$-0.6
Short interest
2.6%
Employees
1k
Rev per Employee
C$260.0k
Show more

Is Canopy Growth Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Canopy Growth Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Canopy Growth Corporation forecast:

1x Buy
8%
4x Hold
31%
8x Sell
62%

Analyst Opinions

13 Analysts have issued a Canopy Growth Corporation forecast:

Buy
8%
Hold
31%
Sell
62%

Financial data from Canopy Growth Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
275 275
4% 4%
100%
- Direct Costs 198 198
1% 1%
72%
77 77
15% 15%
28%
- Selling and Administrative Expenses 126 126
38% 38%
46%
- Research and Development Expense - -
-
-
-49 -49
56% 56%
-18%
- Depreciation and Amortization 24 24
12% 12%
9%
EBIT (Operating Income) EBIT -73 -73
48% 48%
-26%
Net Profit -513 -513
31% 31%
-186%

In millions CAD.

Don't miss a Thing! We will send you all news about Canopy Growth Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Head office Canada
CEO Luc Mongeau
Employees 1,029
Founded 2009
Website www.canopygrowth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today